RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hisamitsu Pharmaceutical Co Stock

Hisamitsu Pharmaceutical Co EBIT 2024

Hisamitsu Pharmaceutical Co EBIT

13.17 B JPY

Ticker

4530.T

ISIN

JP3784600003

WKN

864341

In 2024, Hisamitsu Pharmaceutical Co's EBIT was 13.17 B JPY, a 13.52% increase from the 11.6 B JPY EBIT recorded in the previous year.

The Hisamitsu Pharmaceutical Co EBIT history

YEAREBIT (undefined JPY)
2027e-
2026e-
2025e-
202413.17
202311.6
20229.34
202110.67
202022.73
201922.28
201826.94
201726.31
201627.73
201516.43
201419.12
201325.33
201225.94
201128.2
201028.59
200932.53
200829.1
200726.16
200622.8
200521.52

Hisamitsu Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Hisamitsu Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hisamitsu Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hisamitsu Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Hisamitsu Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Hisamitsu Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Hisamitsu Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hisamitsu Pharmaceutical Co’s growth potential.

Hisamitsu Pharmaceutical Co Revenue, EBIT and net profit per share

DateHisamitsu Pharmaceutical Co RevenueHisamitsu Pharmaceutical Co EBITHisamitsu Pharmaceutical Co Net Income
2027e174.23 B undefined0 undefined20.1 B undefined
2026e167.66 B undefined0 undefined17.19 B undefined
2025e158.57 B undefined0 undefined16.3 B undefined
2024141.71 B undefined13.17 B undefined13.97 B undefined
2023128.33 B undefined11.6 B undefined11.74 B undefined
2022120.19 B undefined9.34 B undefined9.66 B undefined
2021114.51 B undefined10.67 B undefined9.25 B undefined
2020140.99 B undefined22.73 B undefined18.69 B undefined
2019143.41 B undefined22.28 B undefined19.2 B undefined
2018148.47 B undefined26.94 B undefined19.12 B undefined
2017145.93 B undefined26.31 B undefined20.4 B undefined
2016161.85 B undefined27.73 B undefined17.78 B undefined
2015156.74 B undefined16.43 B undefined18.78 B undefined
2014150.64 B undefined19.12 B undefined21.36 B undefined
2013142.77 B undefined25.33 B undefined18.81 B undefined
2012137.79 B undefined25.94 B undefined18.44 B undefined
2011137.18 B undefined28.2 B undefined20.96 B undefined
2010129.83 B undefined28.59 B undefined18.42 B undefined
2009124.66 B undefined32.53 B undefined19.12 B undefined
2008119.06 B undefined29.1 B undefined18.66 B undefined
2007109.79 B undefined26.16 B undefined15.85 B undefined
2006102.67 B undefined22.8 B undefined14.39 B undefined
200583.55 B undefined21.52 B undefined12.81 B undefined

Hisamitsu Pharmaceutical Co stock margins

The Hisamitsu Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hisamitsu Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hisamitsu Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Hisamitsu Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Hisamitsu Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Hisamitsu Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Hisamitsu Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hisamitsu Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hisamitsu Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hisamitsu Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Hisamitsu Pharmaceutical Co Margin History

Hisamitsu Pharmaceutical Co Gross marginHisamitsu Pharmaceutical Co Profit marginHisamitsu Pharmaceutical Co EBIT marginHisamitsu Pharmaceutical Co Profit margin
2027e55.73 %0 %11.54 %
2026e55.73 %0 %10.25 %
2025e55.73 %0 %10.28 %
202455.73 %9.29 %9.86 %
202356.65 %9.04 %9.15 %
202258.3 %7.77 %8.04 %
202160.41 %9.32 %8.08 %
202062.13 %16.12 %13.26 %
201961.84 %15.53 %13.39 %
201862.49 %18.15 %12.88 %
201763.57 %18.03 %13.98 %
201663.97 %17.13 %10.99 %
201563.59 %10.48 %11.98 %
201463.18 %12.69 %14.18 %
201363.82 %17.74 %13.17 %
201266.05 %18.82 %13.38 %
201165.23 %20.55 %15.28 %
201067.14 %22.02 %14.19 %
200968 %26.1 %15.34 %
200869.68 %24.44 %15.68 %
200770.03 %23.82 %14.43 %
200670.93 %22.2 %14.02 %
200570.41 %25.76 %15.34 %

Hisamitsu Pharmaceutical Co Aktienanalyse

What does Hisamitsu Pharmaceutical Co do?

Hisamitsu Pharmaceutical Co Inc is a Japanese company that was founded in 1847. The company is known for its patches and other medical products, making it one of the largest pharmaceutical manufacturers in Japan. The company specializes in the development and production of pharmaceuticals, medical devices, and health and beauty products. They have four main business areas: pharmaceutical products, health products, medical devices, and cosmetics. In addition to their popular Salonpas patches, they also offer a range of other medications, health products, medical devices, and cosmetics. Hisamitsu is committed to improving health and well-being through innovation and collaboration with research institutions and universities. Hisamitsu Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Hisamitsu Pharmaceutical Co's EBIT

Hisamitsu Pharmaceutical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Hisamitsu Pharmaceutical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Hisamitsu Pharmaceutical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Hisamitsu Pharmaceutical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Hisamitsu Pharmaceutical Co stock

How much did Hisamitsu Pharmaceutical Co achieve in EBIT for the current year?

In the current year, Hisamitsu Pharmaceutical Co has achieved an EBIT of 13.17 B JPY.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Hisamitsu Pharmaceutical Co.

How has the EBIT of Hisamitsu Pharmaceutical Co developed in recent years?

The EBIT of Hisamitsu Pharmaceutical Co has increased by 13.518% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Hisamitsu Pharmaceutical Co?

The EBIT of Hisamitsu Pharmaceutical Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Hisamitsu Pharmaceutical Co pay?

Over the past 12 months, Hisamitsu Pharmaceutical Co paid a dividend of 44.5 JPY . This corresponds to a dividend yield of about 1.11 %. For the coming 12 months, Hisamitsu Pharmaceutical Co is expected to pay a dividend of 45.42 JPY.

What is the dividend yield of Hisamitsu Pharmaceutical Co?

The current dividend yield of Hisamitsu Pharmaceutical Co is 1.11 %.

When does Hisamitsu Pharmaceutical Co pay dividends?

Hisamitsu Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of September, March, September, March.

How secure is the dividend of Hisamitsu Pharmaceutical Co?

Hisamitsu Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Hisamitsu Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 45.42 JPY are expected. This corresponds to a dividend yield of 1.13 %.

In which sector is Hisamitsu Pharmaceutical Co located?

Hisamitsu Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hisamitsu Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hisamitsu Pharmaceutical Co from 11/1/2024 amounting to 2 JPY, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.

When did Hisamitsu Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Hisamitsu Pharmaceutical Co in the year 2023?

In the year 2023, Hisamitsu Pharmaceutical Co distributed 42.75 JPY as dividends.

In which currency does Hisamitsu Pharmaceutical Co pay out the dividend?

The dividends of Hisamitsu Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hisamitsu Pharmaceutical Co

Our stock analysis for Hisamitsu Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hisamitsu Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.